RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Carroll Investors, Inc's Holding History (CIK: 0001911400)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 404,936 Value ($000) $1,656 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 396,701 Value ($000) $1,936 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 385,602 Value ($000) $1,951 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 341,331 Value ($000) $1,809 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 246,985 Value ($000) $1,670 Avg Close $6.72 Range $5.60 - $9.55

Q3 2024

Shares 162,740 Value ($000) $1,076 Avg Close $7.17 Range $5.88 - $8.73

Q2 2024

Shares 80,766 Value ($000) $606 Avg Close $8.72 Range $6.75 - $10.66

Q1 2024

Shares 13,799 Value ($000) $138 Avg Close $11.14 Range $8.68 - $15.74

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	404,936	$1,656	$4.95	$3.81 - $7.18
Q3 2025	396,701	$1,936	$5.25	$4.45 - $7.15
Q2 2025	385,602	$1,951	$4.91	$3.79 - $6.11
Q1 2025	341,331	$1,809	$7.29	$5.19 - $12.36
Q4 2024	246,985	$1,670	$6.72	$5.60 - $9.55
Q3 2024	162,740	$1,076	$7.17	$5.88 - $8.73
Q2 2024	80,766	$606	$8.72	$6.75 - $10.66
Q1 2024	13,799	$138	$11.14	$8.68 - $15.74